
Authorised import procedures - COVID-19 Emergency
Authorised import procedures - COVID-19 Emergency
Faced with the shortages of medicines caused by the COVID-19 emergency, the Italian Medicines Agency has authorised the import of foreign packages, replacing the corresponding Italian packages, in order to supply the NHS facilities.
For such supplies, the transmission of movements and values to the Central Database shall be carried out using the corresponding Italian Marketing Authorisation.
Import procedures authorised in the COVID-19 emergency phase
Cooperation among Regions and Autonomous Provinces, AIFA and pharmaceutical companies against shortages of COVID-19 medicines
Site Map
COVID-19 Emergency
- COVID-19 Vaccines
- Medicines usable for treatment of COVID-19 disease
- Monitoring of medicinal products used during the COVID-19 epidemic
- Recommendations on use of medicines in the population exposed to the virus
- Clinical Trials - COVID-19
- Compassionate Use Programs - COVID-19
- COVID-19 Emergency Donations
- Authorised import procedures - COVID-19 Emergency
Nested Applications
Nested Applications
Last tweets
Go to Twitter profile
Multimedia